Streptomycin Price Trend and Forecast

Streptomycin Regional Price Overview

Get the latest insights on price movement and trend analysis of Streptomycin in different regions across the world (Asia, Europe, North America, Latin America, and the Middle East & Africa).

Streptomycin Price Trend for the Q1 of 2024

Asia

In Asia, particularly in the Indian market, streptomycin prices experienced fluctuations due to lower costs of raw materials, which reduced production expenses in the early phase of the quarter. Additionally, decreased inquiries from downstream industries and year-end destocking contributed to the price decline. However, as the months progressed, prices rose as manufacturers like Granules India reported increased profit margins, sparking optimism among traders for future quarters. Furthermore, the National Pharmaceutical Pricing Authority (NPPA) announced an increase in the Maximum Retail Price of essential medicines, including streptomycin, effective April 1, 2024, based on the wholesale price index change from 2022 to 2023.
 

Streptomycin Price Chart

Please Login or Subscribe to Access the Streptomycin Price Chart Data
 

Europe

In Europe, the streptomycin market faced global volatility during the first quarter of 2024, influenced by the dynamic pricing strategies in the US and increased price quotations from Asian traders. The reduction in import volumes from these regions strained inventories amid substantial demand for the commodity.

On the other hand, domestic production struggled with rising feedstock material costs and crude oil prices. Geopolitical tensions from the Middle East, particularly maritime shipment attacks by Houthi communities and sanctions on Russian imports, significantly impacted the pricing trajectory of streptomycin in Q1 2024.

North America

In North America, the United States faced generic drug shortages, partly due to low prices and price capping by overseas industries, posing challenges for healthcare and national security. Manufacturers focused on mitigating these shortages, including proposals to increase domestic drug production. However, the competitive market atmosphere, driven by imports predominantly from India and the EU, raised concerns about dependency on foreign suppliers.

Domestic production solutions are complicated by higher costs and environmental challenges, necessitating significant investments and policy changes. The shortage crisis underscores the need for substantial governmental intervention and strategic investment to secure a stable supply of streptomycin and other essential drugs.

Analyst Insight

According to Procurement Resource, the price trend of Streptomycin is expected to increase by a slight margin based on the raised quotations by several market giants and the escalating cost of production.

Procurement Resource provides latest prices of Streptomycin. Each price database is tied to a user-friendly graphing tool dating back to 2014, which provides a range of functionalities: configuration of price series over user defined time period; comparison of product movements across countries; customisation of price currencies and unit; extraction of price data as excel files to be used offline.